![Monil Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Monil Shah
Corporate Officer/Principal bei
IMUGENE LIMITED
Vermögen: 14 751 $ am 31.05.2026
Profil
Monil Shah was the founder of Ventrus Biosciences, Inc. (founded in 2011) where he held the title of Vice President-Clinical Research & Development from 2011 to 2014.
He is currently the Chief Business Officer at Imugene Ltd. (since 2021) and the Chief Development Officer at WindMIL Therapeutics, Inc. He previously served as the Chief Operating Officer at IRX Therapeutics, Inc. and Eterna Therapeutics LLC (from 2017 to 2018).
Dr. Shah also held the position of VP-Operations & Clinical Development at LTR Pharma Ltd. Dr. Shah obtained undergraduate and doctorate degrees from Rutgers State University of New Jersey.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMUGENE LTD 0,04 % | 30.06.2025 | 178 279 ( 0,04 % ) | 14 751 $ | 31.05.2026 |
Aktive Positionen von Monil Shah
| Unternehmen | Position | Beginn |
|---|---|---|
| IMUGENE LIMITED | Corporate Officer/Principal | 10.06.2021 |
WindMIL Therapeutics, Inc.
 WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Monil Shah
| Unternehmen | Position | Ende |
|---|---|---|
Eterna Therapeutics LLC
 Eterna Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops cytokine-based drugs for the treatment of cancer | Geschäftsführer | 01.10.2018 |
Ventrus Biosciences, Inc.
 Ventrus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets phamaceutical products | Gründer | 01.03.2014 |
IRX Therapeutics, Inc.
 IRX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Geschäftsführer | - |
| LTR PHARMA LIMITED | Corporate Officer/Principal | - |
Ausbildung von Monil Shah
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
13
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
IRX Therapeutics, Inc.
IRX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Ventrus Biosciences, Inc.
Ventrus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets phamaceutical products | Health Technology |
Imugene Ltd.
 Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WindMIL Therapeutics, Inc.
WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Health Technology |
Eterna Therapeutics LLC
Eterna Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops cytokine-based drugs for the treatment of cancer | Health Technology |
Ltr Pharma Ltd.
 Ltr Pharma Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
